The New England Journal of Medicine (NEJM) RSS feed -- Search Results in Dermatology. NEJM (https://www.nejm.org) is a weekly general medical journal that publishes new medical research findings, review articles, and editorial opinion on a wide variety of topics of importance to biomedical science and clinical practice. https://www.nejm.org/action/showPodcastsFeeds NEJM Group Sat, 10 Oct 2026 23:24:33 GMT 2026 NEJM Group en-us 1440 A 44-year-old man was admitted for the management of carcinoid syndrome, which had been diagnosed 4 years earlier. On examination, mottled, violaceous, blanchable flushing was seen across the face and torso. https://www.nejm.org/doi/full/10.1056/NEJMicm2606144?rss=searchAndBrowse https://www.nejm.org/doi/full/10.1056/NEJMicm2606144 N. Karthik, Ashu Rastogi 2026-10-10 Flushing in Carcinoid Syndrome A 35-year-old woman presented with a 20-day history of a nipple ulcer. On examination, there was ulceration, crusting, and a yellowish exudate on the right nipple. https://www.nejm.org/doi/full/10.1056/NEJMicm2605910?rss=searchAndBrowse https://www.nejm.org/doi/full/10.1056/NEJMicm2605910 Yangbin Wang, Chun-Fang Guo 2026-10-08 Syphilitic Chancre on the Nipple Among infants with a family history of allergy, a maternal diet high in eggs and peanuts during pregnancy and lactation did not result in a lower risk of egg or peanut allergy at 1 year than a standard diet. https://www.nejm.org/doi/full/10.1056/NEJMoa2605659?rss=searchAndBrowse https://www.nejm.org/doi/full/10.1056/NEJMoa2605659 Debra J. Palmer, Dianne E. Campbell, Ralph Nanan, Peter S. Hsu, Anita M. Jorgensen, Michael O’Sullivan, Merryn J. Netting, Vicki McWilliam, Susan L. Prescott, Michael S. Gold, Kirsten P. Perrett, Maria Makrides, Thomas R. Sullivan 2026-09-17 Trial of a Maternal Diet Rich in Eggs and Peanuts to Reduce Infant Allergy Food-allergy prevention has undergone a major conceptual shift over the past decade. After years in which avoidance of allergenic foods during infancy, and sometimes during pregnancy and lactation, was considered to be a biologically plausible strategy to prevent food allergy, randomized trials of early infant feeding changed practice by showing... https://www.nejm.org/doi/full/10.1056/NEJMe2610158?rss=searchAndBrowse https://www.nejm.org/doi/full/10.1056/NEJMe2610158 Maria C. Jenmalm 2026-09-17 Maternal Allergen Consumption and Infant Food Allergy — Reassurance, Not Prescription Severe acquired methemoglobinemia was identified in 82 migrants disembarking in Sicily, 74 of whom were treated with methylene blue. Dermal absorption of N-methylaniline was identified as the likely cause. https://www.nejm.org/doi/full/10.1056/NEJMoa2606487?rss=searchAndBrowse https://www.nejm.org/doi/full/10.1056/NEJMoa2606487 Lucia Bernasconi, Davide Lonati, Alessandra Teresi, Francesco D’Arca, Nicolò Ricca, Daniele Merli, Martina Pes, Antonella Rotolo, Elena Grignani, Cristina Agozzino, Cristina Carolina Benussi, Benedetta Brolli, Eleonora Buscaglia, Monica Carnovale, Arianna Centonze, Massimo Ciotta, Francesco Di Lascio, Gerlando Fiorica, Tommaso Frigerio, Fabio Genco, Agostino Massimo Geraci, Giovanni Ippati, Vincenzo Mazzarese, Valentina Maria Negrini, Marco Palmeri, Valeria Margherita Petrolini, Francesco Petrusa, Elisa Roda, Giulia Scaravaggi, Azzurra Schicchi, Sara Scotto, Francesca Zaffino, Carlo Alessandro Locatelli 2026-09-10 Outbreak of Severe Methemoglobinemia during Maritime Migration A 65-year-old man was admitted to this hospital because of fever, intermittent abdominal pain, and rash. The fever began 5 weeks earlier, and palpable purpura developed 1 week before admission. A diagnosis was made. https://www.nejm.org/doi/full/10.1056/NEJMcpc2517855?rss=searchAndBrowse https://www.nejm.org/doi/full/10.1056/NEJMcpc2517855 Jacqueline T. Chu, Robert G. Rasmussen, Jacquelyn M. Nestor, Mack Y. Su 2026-09-10 Case 25-2026: A 65-Year-Old Man with Fever and Rash A 33-year-old man with systemic lupus erythematosus presented with pruritic, burning plaques that evolved into urticarial lesions. Skin biopsy revealed papillary dermal edema, intravascular neutrophils, and C3 deposition. https://www.nejm.org/doi/full/10.1056/NEJMicm2602968?rss=searchAndBrowse https://www.nejm.org/doi/full/10.1056/NEJMicm2602968 Arjun Mahajan, Evan W. Piette 2026-09-03 Urticarial Vasculitis A 72-year-old man presented with a 2-month history of a painful lump on his neck. Cytologic analysis of fine-needle aspirate was consistent with suppurative lymphadenopathy. The lesion subsequently ulcerated and released purulent discharge. https://www.nejm.org/doi/full/10.1056/NEJMicm2517515?rss=searchAndBrowse https://www.nejm.org/doi/full/10.1056/NEJMicm2517515 Ana Rita Ambrosio, Hugo Pego 2026-09-03 Scrofuloderma A 73-year-old woman with rheumatoid arthritis and a 10-month history of pantoprazole therapy presented with skin lesions on her torso. Annular polycyclic lesions were observed on her upper back. https://www.nejm.org/doi/full/10.1056/NEJMicm2605381?rss=searchAndBrowse https://www.nejm.org/doi/full/10.1056/NEJMicm2605381 Norbertus A. Ipenburg, Tobias E. Sangers 2026-08-20 Drug-Induced Subacute Cutaneous Lupus Erythematosus A 61-year-old man with prolonged neutropenia after chemotherapy for AML was evaluated for persistent fever despite antimicrobial therapy. Physical examination was notable for a skin macule with central necrosis on the chest. https://www.nejm.org/doi/full/10.1056/NEJMicm2603271?rss=searchAndBrowse https://www.nejm.org/doi/full/10.1056/NEJMicm2603271 Hanna Osawa, Takahisa Fujino 2026-08-13 Disseminated Fusariosis The selective NaV1.8 inhibitor LTG-001 led to significantly greater reductions in pain scores than placebo over the course of 48 hours among patients who had moderate or severe pain after abdominoplasty. https://www.nejm.org/doi/full/10.1056/NEJMoa2602910?rss=searchAndBrowse https://www.nejm.org/doi/full/10.1056/NEJMoa2602910 Neil Singla, Nathaniel P. Katz, Ben Vaughn, Timothy Rogier, Todd Bertoch, Harold Minkowitz, Mallory Loflin 2026-07-30 Phase 2b Trial of a NaV1.8 Inhibitor for Acute Pain A 35-year-old man with well-controlled plaque psoriasis presented with new skin lesions. Two weeks earlier, he had undergone wet cupping. Physical examination revealed erythematous, scaly papules and plaques on his back. https://www.nejm.org/doi/full/10.1056/NEJMicm2603647?rss=searchAndBrowse https://www.nejm.org/doi/full/10.1056/NEJMicm2603647 Yusuf Demir, Zekayi Kutlubay 2026-07-23 Koebner Phenomenon from Wet Cupping Recombinant DNASE1L3 therapy reduced symptoms in a patient with severe lupus with DNASE1L3 deficiency. Antidrug antibodies caused effects to wane, but findings support NET-targeted therapy as a nonimmunosuppressive approach. https://www.nejm.org/doi/full/10.1056/NEJMc2601997?rss=searchAndBrowse https://www.nejm.org/doi/full/10.1056/NEJMc2601997 Tadej Avčin, Andreas Reiff, Maša Bizjak, Barbara Jenko Bizjan, Tina Vesel Tajnšek, Maruša Debeljak, Tyler Artner, Bernd Jilma, Christian Lood, Abdul Hakkim, Tobias A. Fuchs 2026-07-16 Targeted Degradation of NETs in Lupus with DNASE1L3 Deficiency Peanuts should be introduced at 4 to 6 months of age in infants at high risk for allergy and at approximately 6 months of age in other infants. For infants with peanut allergy, early immunotherapy is safer and more effective. https://www.nejm.org/doi/full/10.1056/NEJMcp2314424?rss=searchAndBrowse https://www.nejm.org/doi/full/10.1056/NEJMcp2314424 George Du Toit, Gideon Lack 2026-06-25 Prevention and Treatment of Peanut Allergy A 5-month-old full-term boy was brought to the clinic with a 3-week history of rash. The baby was irritable, with sparse hair, pitting edema of the limbs, and desquamation of hyperpigmented patches on the limbs and trunk. https://www.nejm.org/doi/full/10.1056/NEJMicm2602658?rss=searchAndBrowse https://www.nejm.org/doi/full/10.1056/NEJMicm2602658 Jashir Ahammed Kolathil, Gadhiraju Manisha Varma 2026-06-25 Kwashiorkor Among patients with moderate or severe PTS, the addition of endovascular therapy to standard care resulted in less severe PTS and better quality of life at 6 months than standard care alone but with a higher risk of bleeding. https://www.nejm.org/doi/full/10.1056/NEJMoa2519001?rss=searchAndBrowse https://www.nejm.org/doi/full/10.1056/NEJMoa2519001 Suresh Vedantham, Susan R. Kahn, William A. Marston, Ido Weinberg, Akhilesh K. Sista, Elizabeth A. Magnuson, David J. Cohen, Suman M. Wasan, Mahmood K. Razavi, Samuel Z. Goldhaber, Kristen M. Sanfilippo, Anthony J. Comerota, Ezana M. Azene, Cassius Iyad Ochoa Chaar, Daniel A. Leung, K. Pallav Kolli, Sanjeeva P. Kalva, Nassir Rostambeigi, Ajinkya Desai, Kush R. Desai, Alfonso J. Tafur, Bhavraj Khalsa, Elaine Majerus, Borong Wang, Yang Wang, Patricia Nieters, Mary Clare Derfler, Angela Oliver, Cassandra Hardy, Riyaz Bashir, Ronald Winokur, Natalie Weger, Minhaj S. Khaja, Aditya Sharma, Naganathan Mani, Pavan Kavali, Siddhant Thukral, Leslie L. Lake, Kathryn Mikkelsen, Sameer Parpia, the C-TRACT Trial Investigators* 2026-06-18 Endovascular Therapy for Post-Thrombotic Syndrome — A Randomized Trial Post-thrombotic syndrome is the most common chronic complication of deep-vein thrombosis (DVT), affecting 20 to 50% of patients with DVT and causing debilitating symptoms involving the limbs — including pain, swelling, skin changes, and venous ulcers — that substantially reduce quality of life and impose considerable socioeconomic burden.1 ... https://www.nejm.org/doi/full/10.1056/NEJMe2603048?rss=searchAndBrowse https://www.nejm.org/doi/full/10.1056/NEJMe2603048 Ronald Luiz Gomes Flumignan, Luís Carlos Uta Nakano 2026-06-18 Stenting for Post-Thrombotic Syndrome — A Step Forward A 38-year-old pregnant former agricultural worker was referred to the dermatology clinic for evaluation of a long-standing, itchy lesion on her abdomen. Histopathological analysis showed thick-walled, brown, septate spores. https://www.nejm.org/doi/full/10.1056/NEJMicm2600078?rss=searchAndBrowse https://www.nejm.org/doi/full/10.1056/NEJMicm2600078 Eva R. Parker, Lili Tao 2026-06-18 Chromoblastomycosis In a trial of brepocitinib in adults with dermatomyositis, the 30-mg dose (but not the 15-mg dose) led to greater improvement on a composite myositis index at 52 weeks than placebo. Serious infections were more frequent with the 30-mg dose. https://www.nejm.org/doi/full/10.1056/NEJMoa2503531?rss=searchAndBrowse https://www.nejm.org/doi/full/10.1056/NEJMoa2503531 Ruth Ann Vleugels, Julie J. Paik, Iazsmin Bauer Ventura, Aaron R. Mangold, Prateek C. Gandiga, Anna Haemel, Hector Chinoy, Yessar M. Hussain, Kumaraswamy Sivakumar, Zoltan Griger, Eun Bong Lee, Francisca Bozan, Chung-Yuan Hsu, Alisa Femia, Mazen M. Dimachkie, Michelle S. Min, Tahseen Mozaffar, Christina Charles-Schoeman, David R. Fernandez, Oluwakemi Onajin, Raquel Campanilho-Marques, Galina Marder, Floranne Ernste, Elena Schiopu, Jason Sluzevich, David Pearson, Stephen Lindsey, Michael Luggen, Michael R. Bubb, Erin Boh, Rashmi Maganti, Latisha Heinlen, Katharina S. Shaw, Matthew D. Cascino, Paul N. Mudd Jr., Jiri Vencovsky, Anthony P. Fernandez, David Fiorentino, Lisa Christopher-Stine, Victoria P. Werth, Rohit Aggarwal, the VALOR Investigators* 2026-05-14 A Phase 3 Trial of Brepocitinib in Dermatomyositis Dermatomyositis is a subgroup of idiopathic inflammatory myopathies — systemic autoimmune disorders that are typically characterized by the involvement of multiple organs, including muscle, skin, joints, lungs, gastrointestinal tract, and heart — all conditions with high morbidity and mortality.1 Treatment of myositis is based on off-label use of... https://www.nejm.org/doi/full/10.1056/NEJMe2604009?rss=searchAndBrowse https://www.nejm.org/doi/full/10.1056/NEJMe2604009 Ingrid E. Lundberg 2026-05-14 A Phase 3 Trial of Brepocitinib in Dermatomyositis